Vivanza Biosci.

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE984E01035
NSEID:
BSEID: 530057

INR

2.03

-0.05 (-2.4%)

BSENSE

Dec 17

BSE+NSE Vol: 22.64 k

{
  "main_header": {
    "sid": 515837,
    "name": "Vivanza Biosci.",
    "stock_name": "Vivanza Biosci.",
    "full_name": "Vivanza Biosciences Ltd",
    "name_url": "stocks-analysis/vivanza-biosci",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "2.03",
    "chg": -0.05,
    "chgp": "-2.4%",
    "dir": -1,
    "prev_price": "2.08",
    "mcapval": "8.12 Cr",
    "mcap": "Micro Cap",
    "scripcode": 530057,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 67,
    "indexname": "",
    "isin": "INE984E01035",
    "curr_date": "Dec 17",
    "curr_time": "",
    "bse_nse_vol": "22.64 k",
    "exc_status": "Active",
    "traded_date": "Dec 17, 2025",
    "traded_date_str": "2025 12 17",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/vivanza-biosci-515837-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Vivanza Biosci. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-vivanza-biosci-fallingrising-3755661",
        "imagepath": "",
        "date": "2025-12-11 00:38:06",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>Vivanza Biosciences’ share price fell by ₹0.10 on 10 December, representing a 4.57% decrease as of 8:38 PM. This decline is part of a broader trend of underperformance relative to the Sensex and its sector peers. Over the past week, the stock has dropped by 2.34%, compared to a more modest 0.84% decline in the Sensex. Although the stock recorded a positive return of 6.09% over the last month, this short-term gain contrasts sharply with its longer-term performance.</p>\n<p>Year-to-date, Vivanza Biosciences has suffered a steep loss of 39.94%, while the Sensex has gained 8.00%. Over the past year, the stock’s decline of 39.77% starkly contrasts with the Sensex’s 3.53% rise. The longer-term picture is even more concerning, with the stock d..."
      },
      {
        "title": "Vivanza Biosci. Sees Revision in Market Evaluation Amid Challenging Fundamentals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vivanza-biosci-downgraded-to-strong-sell-amid-weak-fundamentals-and-risky-valuation-3755092",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/VivanzaBiosci_mojoScore_3755092.png",
        "date": "2025-12-10 10:10:40",
        "description": "Vivanza Biosci., a microcap player in the Pharmaceuticals & Biotechnology sector, has undergone a revision in its market evaluation reflecting shifts in its fundamental and technical outlook. This adjustment highlights ongoing challenges in the company’s financial health and market positioning, underscoring the importance of closely monitoring its evolving performance metrics."
      },
      {
        "title": "Vivanza Biosciences Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vivanza-biosciences-faces-severe-selling-pressure-amid-lower-circuit-lockdown-3744396",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/VivanzaBioscien_only_sellers_3744396.png",
        "date": "2025-12-03 14:20:20",
        "description": "Vivanza Biosciences Ltd is currently experiencing severe selling pressure, with the stock hitting a lower circuit and an order book dominated exclusively by sell orders. This extreme market behaviour signals distress selling and a lack of buyer interest, reflecting a challenging phase for the pharmaceutical and biotechnology company."
      },
      {
        "title": "Vivanza Biosciences Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vivanza-biosciences-faces-severe-selling-pressure-hits-lower-circuit-amid-distress-signals-3733661",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/VivanzaBioscien_only_sellers_3733661.png",
        "date": "2025-11-27 12:25:26",
        "description": "Vivanza Biosciences Ltd is experiencing a pronounced sell-off, marked by a lower circuit scenario with exclusively sell orders dominating the queue. The stock’s performance today reflects severe distress selling, with no buyers stepping in to absorb the pressure, signalling heightened investor concern in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Vivanza Biosciences Surges with Unprecedented Buying Interest, Poised for Multi-Day Upper Circuit",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vivanza-biosciences-hits-upper-circuit-amidst-unprecedented-buying-interest-3725378",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/VivanzaBioscien_only_buyers_3725378.png",
        "date": "2025-11-24 11:35:27",
        "description": "Vivanza Biosciences Ltd has captured market attention with extraordinary buying momentum, registering a sharp price rise accompanied by an absence of sellers. This rare scenario suggests the stock may sustain its upper circuit status over multiple sessions, reflecting intense demand within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Vivanza Biosciences Surges with Unprecedented Buying Interest Amid Upper Circuit Lock",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vivanza-biosciences-hits-upper-circuit-amid-unprecedented-buying-interest-3720588",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/VivanzaBioscien_only_buyers_3720588.png",
        "date": "2025-11-21 10:35:30",
        "description": "Vivanza Biosciences has witnessed extraordinary buying momentum today, with the stock hitting the upper circuit and registering only buy orders in the queue. This rare market phenomenon signals intense demand and the possibility of a sustained multi-day circuit scenario, setting the stage for close investor attention in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Vivanza Biosciences Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vivanza-biosciences-faces-severe-selling-pressure-amid-lower-circuit-lockdown-3718442",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/VivanzaBioscien_only_sellers_3718442.png",
        "date": "2025-11-20 15:25:30",
        "description": "Vivanza Biosciences Ltd, a player in the Pharmaceuticals & Biotechnology sector, is currently experiencing significant selling pressure, marked by a lower circuit scenario with only sell orders in the queue. The stock has recorded consecutive declines over the past four days, signalling distress selling and a lack of buyer interest amid a challenging market environment."
      },
      {
        "title": "Vivanza Biosciences Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vivanza-biosciences-faces-extreme-selling-pressure-amid-lower-circuit-trigger-3715110",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/VivanzaBioscien_only_sellers_3715110.png",
        "date": "2025-11-19 10:30:47",
        "description": "Vivanza Biosciences Ltd is currently experiencing significant selling pressure, with only sell orders present in the queue today. The stock has recorded a sharp decline of 4.66% in a single day, underperforming the Sensex which posted a modest gain of 0.27%. This distress selling signals heightened investor caution in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Why is Vivanza Biosci. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-vivanza-biosci-fallingrising-3713008",
        "imagepath": "",
        "date": "2025-11-18 22:29:26",
        "description": "As of 18-Nov, Vivanza Biosciences Ltd is currently priced at 2.36, reflecting a decline of 0.12 or 4.84%. The stock has been underperforming, having lost 9.58% over the last two days and underperformed its sector by 4.21% today. Despite this recent downturn, the stock has shown a positive trend over the past week and month, with returns of 19.19% and 18.59%, respectively. However, it has experienced significant declines year-to-date and over the past year, with losses of 32.18% and 42.16%. Additionally, there has been a notable decrease in investor participation, with delivery volume falling by 36.86% compared to the five-day average, indicating reduced trading interest.\n\nBroader market context shows that while Vivanza's short-term performance has been strong relative to its recent history, it still lags behind the benchmark Sensex, which has gained 0.96% over the past week and 0.86% over the past month. Th..."
      }
    ],
    "total": 156,
    "sid": "515837",
    "stock_news_url": "https://www.marketsmojo.com/news/vivanza-biosciences-515837"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "12-Dec-2025",
      "details": "Pursuant to regulation 30read with Schedule III Part A Para A of SEBI (LODR) regulations 2015 we enclose copies of the newspaper advertisments publisherd by the company on 12th December 2025 a reminder regarding the opening of Special Window for re-lodgement of transfer requests of physical shares in accordance with SEBI Circular No. SEBI/HO/MIRSD/MIRSD-POD/P/CIR/2025/97 dated 2nd July 2025. the said circular is also available on Companies Website.",
      "source": "BSE"
    },
    {
      "caption": "Reg. 34 (1) Annual Report.",
      "datetime": "04-Dec-2025",
      "details": "This is to inform that pursuant to Regulation 34 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 and in continuation of our intimation dated 04th September 2025 regarding Submission of Annual Report for the Financial Year 2024-25 the Company hereby submits the revised Annual Report for the F.Y. 2024- 25. We further wish to state that the previous Annual Report contained improper formatting and changes which are being revised in this revised Annual Report.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "15-Nov-2025",
      "details": "Pursuant to Regulation 30 of SEBI (LODR) Regulations 2015 we hereby enclose the copies of the postal ballot notice for seeking approval of members of the company the amendementof the Object Clause of the Memorandum of Association (MOA) of the Company as published in the following newspaper: 1. Indian Express in English 2. Financial Express in Gujrati",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Vivanza Biosciences Ltd has announced <strong>1:10</strong> stock split, ex-date: 24 Mar 23",
          "dt": "2023-03-24",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Why is Vivanza Biosci. falling/rising?

2025-12-11 00:38:06

Recent Price Movement and Market Context

Vivanza Biosciences’ share price fell by ₹0.10 on 10 December, representing a 4.57% decrease as of 8:38 PM. This decline is part of a broader trend of underperformance relative to the Sensex and its sector peers. Over the past week, the stock has dropped by 2.34%, compared to a more modest 0.84% decline in the Sensex. Although the stock recorded a positive return of 6.09% over the last month, this short-term gain contrasts sharply with its longer-term performance.

Year-to-date, Vivanza Biosciences has suffered a steep loss of 39.94%, while the Sensex has gained 8.00%. Over the past year, the stock’s decline of 39.77% starkly contrasts with the Sensex’s 3.53% rise. The longer-term picture is even more concerning, with the stock d...

Vivanza Biosci. Sees Revision in Market Evaluation Amid Challenging Fundamentals

2025-12-10 10:10:40

Vivanza Biosci., a microcap player in the Pharmaceuticals & Biotechnology sector, has undergone a revision in its market evaluation reflecting shifts in its fundamental and technical outlook. This adjustment highlights ongoing challenges in the company’s financial health and market positioning, underscoring the importance of closely monitoring its evolving performance metrics.

Vivanza Biosciences Faces Intense Selling Pressure Amid Consecutive Losses

2025-12-03 14:20:20

Vivanza Biosciences Ltd is currently experiencing severe selling pressure, with the stock hitting a lower circuit and an order book dominated exclusively by sell orders. This extreme market behaviour signals distress selling and a lack of buyer interest, reflecting a challenging phase for the pharmaceutical and biotechnology company.

Vivanza Biosciences Faces Intense Selling Pressure Amid Consecutive Losses

2025-11-27 12:25:26

Vivanza Biosciences Ltd is experiencing a pronounced sell-off, marked by a lower circuit scenario with exclusively sell orders dominating the queue. The stock’s performance today reflects severe distress selling, with no buyers stepping in to absorb the pressure, signalling heightened investor concern in the Pharmaceuticals & Biotechnology sector.

Vivanza Biosciences Surges with Unprecedented Buying Interest, Poised for Multi-Day Upper Circuit

2025-11-24 11:35:27

Vivanza Biosciences Ltd has captured market attention with extraordinary buying momentum, registering a sharp price rise accompanied by an absence of sellers. This rare scenario suggests the stock may sustain its upper circuit status over multiple sessions, reflecting intense demand within the Pharmaceuticals & Biotechnology sector.

Vivanza Biosciences Surges with Unprecedented Buying Interest Amid Upper Circuit Lock

2025-11-21 10:35:30

Vivanza Biosciences has witnessed extraordinary buying momentum today, with the stock hitting the upper circuit and registering only buy orders in the queue. This rare market phenomenon signals intense demand and the possibility of a sustained multi-day circuit scenario, setting the stage for close investor attention in the Pharmaceuticals & Biotechnology sector.

Vivanza Biosciences Faces Intense Selling Pressure Amid Consecutive Losses

2025-11-20 15:25:30

Vivanza Biosciences Ltd, a player in the Pharmaceuticals & Biotechnology sector, is currently experiencing significant selling pressure, marked by a lower circuit scenario with only sell orders in the queue. The stock has recorded consecutive declines over the past four days, signalling distress selling and a lack of buyer interest amid a challenging market environment.

Vivanza Biosciences Faces Intense Selling Pressure Amid Consecutive Losses

2025-11-19 10:30:47

Vivanza Biosciences Ltd is currently experiencing significant selling pressure, with only sell orders present in the queue today. The stock has recorded a sharp decline of 4.66% in a single day, underperforming the Sensex which posted a modest gain of 0.27%. This distress selling signals heightened investor caution in the Pharmaceuticals & Biotechnology sector.

Why is Vivanza Biosci. falling/rising?

2025-11-18 22:29:26

As of 18-Nov, Vivanza Biosciences Ltd is currently priced at 2.36, reflecting a decline of 0.12 or 4.84%. The stock has been underperforming, having lost 9.58% over the last two days and underperformed its sector by 4.21% today. Despite this recent downturn, the stock has shown a positive trend over the past week and month, with returns of 19.19% and 18.59%, respectively. However, it has experienced significant declines year-to-date and over the past year, with losses of 32.18% and 42.16%. Additionally, there has been a notable decrease in investor participation, with delivery volume falling by 36.86% compared to the five-day average, indicating reduced trading interest. Broader market context shows that while Vivanza's short-term performance has been strong relative to its recent history, it still lags behind the benchmark Sensex, which has gained 0.96% over the past week and 0.86% over the past month. Th...

View All News

Announcement

Announcement under Regulation 30 (LODR)-Newspaper Publication

12-Dec-2025 | Source : BSE

Pursuant to regulation 30read with Schedule III Part A Para A of SEBI (LODR) regulations 2015 we enclose copies of the newspaper advertisments publisherd by the company on 12th December 2025 a reminder regarding the opening of Special Window for re-lodgement of transfer requests of physical shares in accordance with SEBI Circular No. SEBI/HO/MIRSD/MIRSD-POD/P/CIR/2025/97 dated 2nd July 2025. the said circular is also available on Companies Website.

Reg. 34 (1) Annual Report.

04-Dec-2025 | Source : BSE

This is to inform that pursuant to Regulation 34 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 and in continuation of our intimation dated 04th September 2025 regarding Submission of Annual Report for the Financial Year 2024-25 the Company hereby submits the revised Annual Report for the F.Y. 2024- 25. We further wish to state that the previous Annual Report contained improper formatting and changes which are being revised in this revised Annual Report.

Announcement under Regulation 30 (LODR)-Newspaper Publication

15-Nov-2025 | Source : BSE

Pursuant to Regulation 30 of SEBI (LODR) Regulations 2015 we hereby enclose the copies of the postal ballot notice for seeking approval of members of the company the amendementof the Object Clause of the Memorandum of Association (MOA) of the Company as published in the following newspaper: 1. Indian Express in English 2. Financial Express in Gujrati